ALXN Forex Aktualności
BioLight Inks Agreement With Alexion To Explore Technology For Diagnosis Of Retinal Diseases
BioLight Life Sciences Ltd. announced Tuesday it has signed a research collaboration agreement with Alexion Pharmaceuticals, Inc. (ALXN), a subsidiary of AstraZeneca plc (AZN, AZN.L), focusing on exploring a groundbreaking technology that utilizes natural tears for the potential diagnosis of retinal diseases.
RTTNews
|
508 dni temu
